DELAVAYIN-A;CYClO-(-GLY-SER-GAMMA-HYDROXY-ILE-PHE-PHE-ALA-)
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 2Te8G19bSz4 |
|---|---|
| InChI | InChI=1S/C32H42N6O8/c1-18(20(3)40)27-32(46)37-24(15-22-12-8-5-9-13-22)30(44)36-23(14-21-10-6-4-7-11-21)29(43)34-19(2)28(42)33-16-26(41)35-25(17-39)31(45)38-27/h4-13,18-20,23-25,27,39-40H,14-17H2,1-3H3,(H,33,42)(H,34,43)(H,35,41)(H,36,44)(H,37,46)(H,38,45)/t18?,19-,20?,23-,24-,25-,27-/m0/s1 |
| InChIKey | MUIJADDNJGTWGO-BGMURVEOSA-N |
| Mol Weight | 638.7 g/mol |
| Molecular Formula | C32H42N6O8 |
| Exact Mass | 638.306412 g/mol |
| Enantiomer InChIKey | MUIJADDNJGTWGO-DFMOGVKBSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | PYRIDINE-D5 |
D-ALA-SER-THR-THR-ASN-TYR-THR-NH2
CROTOGOSSAIDE;CYCLO-(-GLY-(1)-ALA-(2)-SER-(3)-GLY-(4)-LEU-(5)-ASN-(6)-GLY-(7)-ILE-(8)-PHE-(9)-)
SOLONAMIDE-B
1962_B
TEOC-(3-NCP)ALA-PHE-VAL-OME
BEAUVERIOLIDE-VII
N-TERT.-BUTYLOXYCARBONYL-GLYCYL-(S-PALMITOYL)-L-CYSTEYL-L-THREONYL-L-LEUCYL-L-SERYL-L-ALANINE;BOC-GLY-CYS(PAL)-THR-LEU-SER-ALA-OH
Tryptophyl-seryl-tyrosyl-glycine
2-[[2-[[2-[[2-[[2-[[2-[[2-[(2-amino-5-hydroxy-5-keto-pentanoyl)amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-hydroxy-5-keto-pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methyl-pentanoyl]amino]-4-hydroxy-4-keto-butanoyl]amino]-3-(4-hydroxyphenyl)p
L-Glutamic acid, N-[N-[N-[S-(2-methoxy-2-oxoethyl)-N-(trifluoroacetyl)-L-cysteinyl]-O-methyl-L-tyrosyl]-L-phenylalanyl]-, dimethyl ester
| Title | Journal or Book | Year |
|---|---|---|
| Cyclic Peptides from Higher Plants. 33. Delavayins A−C, Three New Cyclic Peptides from Stellaria delavayi | Journal of Natural Products | 1997 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.